Business Insider: Companies You've Never Heard of Are About to Incite Massive Drug Price Outrage
Wednesday, September 14, 2016
Posted by: Dagmar Anderson
An insightful Business Insider view of PBMs, drug pricing issues and their impact upon patients published on September 12th: "These Companies You've Never Heard of are About to Incite Another Massive Drug Price Outrage."
From the article: "It's easy to see why EpiPen has become the focus of America's fury over drug prices. It treats potentially deadly allergic reactions — for example, in a child who is stung by a bee — and its price has spiked by over 500% in a few years."
While it's easy to jump all over drugmakers, like EpiPen's maker, Mylan, other actors in the healthcare system ought to draw as much scrutiny.
One group of companies, called pharmaceutical-benefit managers, or PBMs, serve as middlemen, and they touch every part of the purchase of a prescription drug."
From Your IACP Reimbursement Committee Chair
IACP's Reimbursement & Insurance Committee is working, along with industry partners, to ensure IACP Members’ voices and reimbursement/third party concerns are kept front and center on Capitol Hill.
Please email IACP at email@example.com with any questions or reimbursement issues impacting your practice.
- Scott Popyk, RPh, MBA, FIACP, IACP Reimbursement Committee Chair
Click here to read the entire Business Insider article.